Arpa Garay, Chief Commercial Officer at Moderna, Inc. (MRNA), sold 1,148 shares at $108.40 ($124K) on 2023-09-06, disclosed to the SEC on 2023-09-07.
Scheduled sale ($124k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.40 | 574 | $62K | 50.0% |
| 2 | $108.40 | 574 | $62K | 50.0% |
| Total | $108.40 avg | 1,148 | $124K | 100% |
| Filing → |